Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma

Journal for Immunotherapy of Cancer
Yong LiFengjun Cao

Abstract

Interferon-α (IFN-α) plays a pivotal role in host antitumor immunity, and the evasion of IFN-α signaling pathway can lead to IFN-α resistance during the treatment of cancer. Although the interplay between IFN-α and tumor cells has been extensively investigated in differentiated tumor cells, much less attention has been directed to tumor-repopulating cells (TRCs). Three-dimentional soft fibrin matrix was used to select and grow highly malignant and tumorigenic melanoma TRCs. The regulation of integrin β3 (ITGB3)-c-SRC-STAT signaling pathway in melanoma TRCs was investigated both in vitro and in vivo. The relevant mRNA and protein expression levels were analyzed by qRT-PCR and western blot analysis. Immunoprecipitation and chromatin immunoprecipitation (ChIP) followed by qPCR (ChIP-qPCR) assays were performed to detect protein-protein and protein-DNA interactions. The clinical impacts of retinoic acid inducible gene-I (RIG-I) were assessed in melanoma datasets obtained from The Cancer Genome Atlas and Gene Expression Omnibus profiles. IFN-α-induced apoptosis was decreased in melanoma TRCs. Compared with conventional flask-cultured cells, IFN-α-mediated STAT1 activation was diminished in melanoma TRCs. Decreased expression of RIG-...Continue Reading

References

Jan 1, 1983·Cancer Metastasis Reviews·H F DvorakA M Dvorak
Oct 12, 2001·Clinical Cardiology·J AlaeddiniJ Shirani
Mar 29, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·S LandolfoR Foa
Nov 1, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elena G Arias-SalgadoSanford J Shattil
Jul 31, 2004·The Journal of Biological Chemistry·Yulan Qing, George R Stark
Apr 20, 2005·Advances in Protein Chemistry·John W Weisel
May 3, 2005·Nature Reviews. Immunology·Leonidas C Platanias
Mar 31, 2006·The Journal of Biological Chemistry·Hao H Ho, Lionel B Ivashkiv
Aug 22, 2006·Current Opinion in Cell Biology·Satyajit K Mitra, David D Schlaepfer
Oct 26, 2006·Nature Reviews. Immunology·Gavin P DunnRobert D Schreiber
Jul 20, 2007·Genes & Development·Brooke AncrileChristopher M Counter
Dec 5, 2008·Nature·Elsa QuintanaSean J Morrison
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dusan BogunovicNina Bhardwaj
Dec 24, 2009·Nature Reviews. Cancer·Jay S Desgrosellier, David A Cheresh
May 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Göran JönssonPer Eystein Lønning
Dec 16, 2010·Cancer Cell·Anders I PerssonWilliam A Weiss
Dec 24, 2010·The New England Journal of Medicine·Claude PreudhommeUNKNOWN France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC)
Aug 4, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wei-Bei WangChien-Kuo Lee
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahmad A TarhiniJohn M Kirkwood
Jul 4, 2012·Nature Materials·Jing LiuBo Huang
Aug 21, 2013·Immunology and Cell Biology·Nicole L MessinaRicky W Johnstone
Apr 22, 2014·Nature Cell Biology·Laetitia SeguinDavid A Cheresh
Jun 5, 2014·International Journal of Cancer. Journal International Du Cancer·Chanyu YueAna M Gamero
Oct 25, 2014·Nature Reviews. Cancer·Hua YuRichard Jove
Dec 19, 2014·BMC Cancer·Chirayu Pankaj Goswami, Harikrishna Nakshatri
Jan 13, 2015·Trends in Cell Biology·Laetitia SeguinDavid A Cheresh
Jun 2, 2015·Nature Reviews. Immunology·Laurence ZitvogelGuido Kroemer
Feb 26, 2016·Nature Reviews. Cancer·Belinda S ParkerPaul J Hertzog
May 25, 2016·Cancer Research·Xinming SuKatherine N Weilbaecher
Jun 9, 2017·Protein & Cell·Xiao-Xiao XuJian-Zhong Shao
Nov 9, 2017·Nature Reviews. Clinical Oncology·Ibiayi Dagogo-Jack, Alice T Shaw
Jan 23, 2018·Journal of Leukocyte Biology·Kei-Ichiro ArimotoDong-Er Zhang
Feb 13, 2018·The Journal of Clinical Investigation·Yuying LiuBo Huang
Apr 21, 2018·Annual Review of Immunology·Kwan T ChowYueh-Ming Loo
Jan 27, 2019·Nature Reviews. Drug Discovery·Ernest C Borden
Apr 4, 2019·Journal of Hematology & Oncology·Claudia SchubertSteffen Koschmieder

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
immunoprecipitation
flow cytometry
nuclear translocation
confocal microscopy

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.